Altogether, our results uncover an important link between the MEK5/ERK5 cascade and p53-dependent apoptosis triggered by 5-FU, where ERK5-targeted inhibition arises as a promising therapeutic approach for colon cancer treatment and chemosensitization. This evidence concerns the gene MAP2K5 and colonic neoplasm.